WO2011080716A3 - Composition pharmaceutique pour l'administration modifiée de principes actifs - Google Patents
Composition pharmaceutique pour l'administration modifiée de principes actifs Download PDFInfo
- Publication number
- WO2011080716A3 WO2011080716A3 PCT/IB2010/056139 IB2010056139W WO2011080716A3 WO 2011080716 A3 WO2011080716 A3 WO 2011080716A3 IB 2010056139 W IB2010056139 W IB 2010056139W WO 2011080716 A3 WO2011080716 A3 WO 2011080716A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- core
- rate controlling
- surrounding
- actives
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10816429.4A EP2521537A2 (fr) | 2010-01-04 | 2010-12-30 | Composition pharmaceutique pour l'administration modifiee de principes actifs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN11MU2010 | 2010-01-04 | ||
IN11/MUM/2010 | 2010-01-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011080716A2 WO2011080716A2 (fr) | 2011-07-07 |
WO2011080716A3 true WO2011080716A3 (fr) | 2012-01-26 |
Family
ID=44226914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2010/056139 WO2011080716A2 (fr) | 2010-01-04 | 2010-12-30 | Composition pharmaceutique pour l'administration modifiée de principes actifs |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2521537A2 (fr) |
WO (1) | WO2011080716A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107944A2 (fr) * | 2010-03-04 | 2011-09-09 | Wockhardt Limited | Forme pharmaceutique à libération modifiée |
US11576920B2 (en) | 2019-03-18 | 2023-02-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630166B1 (en) * | 2001-02-12 | 2003-10-07 | Watson Pharmaceuticals, Inc. | Compositions for conjugated estrogens and associated methods |
US20060280790A1 (en) * | 2005-04-08 | 2006-12-14 | Ju Tzuchi R | Pharmaceutical formulations |
US20060287352A1 (en) * | 2003-08-29 | 2006-12-21 | Per Holm | Modified release compositions comprising tacrolimus |
WO2007035816A2 (fr) * | 2005-09-20 | 2007-03-29 | Dr. Reddy's Laboratories Ltd. | Compositions de paroxétine |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
IT1188212B (it) | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4971790A (en) | 1986-02-07 | 1990-11-20 | Alza Corporation | Dosage form for lessening irritation of mocusa |
US4814183A (en) | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
US4946686A (en) | 1987-09-24 | 1990-08-07 | Merck & Co., Inc. | Solubility modulated drug delivery system |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
IT1237904B (it) | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
US5543154A (en) | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
IT1265240B1 (it) | 1993-11-30 | 1996-10-31 | Ekita Investments Nv | Compressa farmaceutica a rilascio controllato, di forma lenticolare |
US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
IL119627A (en) | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
CA2216215A1 (fr) | 1997-04-05 | 1998-10-05 | Isa Odidi | Formulations a liberation prolongee, utilisant des polymeres intelligents, avec caracteristiques de mouillabilite opposees, correspondant a une hydrophobie et a une hydrophilie |
US6607751B1 (en) | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6720005B1 (en) | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
WO2006044202A2 (fr) | 2004-10-19 | 2006-04-27 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Compositions a revetement enterique qui liberent un/des principe(s) actif(s) dans les liquides gastro-intestinaux |
EP1858493A4 (fr) | 2005-03-14 | 2010-12-01 | Sun Pharmaceutical Ind Ltd | Systeme d'administration de medicament par voie orale |
EP2263657B1 (fr) | 2009-05-20 | 2013-07-17 | Ranbaxy Laboratories Limited | Formulations de lamotrigine à libération contrôlée |
-
2010
- 2010-12-30 EP EP10816429.4A patent/EP2521537A2/fr not_active Withdrawn
- 2010-12-30 WO PCT/IB2010/056139 patent/WO2011080716A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630166B1 (en) * | 2001-02-12 | 2003-10-07 | Watson Pharmaceuticals, Inc. | Compositions for conjugated estrogens and associated methods |
US20060287352A1 (en) * | 2003-08-29 | 2006-12-21 | Per Holm | Modified release compositions comprising tacrolimus |
US20060280790A1 (en) * | 2005-04-08 | 2006-12-14 | Ju Tzuchi R | Pharmaceutical formulations |
WO2007035816A2 (fr) * | 2005-09-20 | 2007-03-29 | Dr. Reddy's Laboratories Ltd. | Compositions de paroxétine |
Also Published As
Publication number | Publication date |
---|---|
EP2521537A2 (fr) | 2012-11-14 |
WO2011080716A2 (fr) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012034079A3 (fr) | Formes pharmaceutiques de type macrolides | |
WO2008100375A3 (fr) | Films à base de polymères et systèmes de délivrance de médicaments fabriqués à partir de ceux-ci | |
WO2009113703A3 (fr) | Préparation solide orodispersible | |
MX350380B (es) | Formas de dosificacion solida de liberacion modificada en el orden de cero. | |
CL2015000544A1 (es) | Una composicion farmaceutica que comprende regorafenib y al menos un excipiente farmaceuticamente aceptable, en el que la composicion esta recubierta por un recubrimiento que comprende un polimero basado en alcohol polivinilico; y su procedimiento de preparacion. | |
MX356111B (es) | Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata. | |
WO2006099514A3 (fr) | Composition d'administration de medicaments contenant un polymere et un agent modificateur | |
WO2010006143A3 (fr) | Dispositif d'administration transdermique d'oestrogènes | |
WO2011139486A3 (fr) | Dispositif stratifié d'administration de médicament | |
WO2009010837A3 (fr) | Nanoparticules comprenant un polymère non ionisable et un polymère cellulosique anionique | |
WO2008149192A3 (fr) | Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable | |
WO2011053003A3 (fr) | Formulation à rétention gastrique et à libération prolongée contenant de la prégabaline, un oxyde de polyéthylène et un copolymère greffé pva-peg | |
MX2010007577A (es) | Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon. | |
WO2011101866A3 (fr) | Méthode de traitement d'une affection sensible à une thérapie par baclofène | |
WO2011067667A3 (fr) | Microcapsules de fexofénadine et compositions les contenant | |
WO2009001099A3 (fr) | Composition pharmaceutique | |
NZ608598A (en) | A transdermal drug administration device | |
WO2007083323A3 (fr) | Administration orale de desmopressine et de ses sels | |
WO2012091748A3 (fr) | Système d'administration par réservoir d'agent thérapeutique | |
WO2011143118A3 (fr) | Formulations résistantes à l'alcool | |
WO2011107944A3 (fr) | Forme pharmaceutique à libération modifiée | |
WO2008152398A3 (fr) | Formulations pour inhalation | |
WO2014016671A3 (fr) | Formulations et procédés de fabrication de formulations destinées à être utilisées en évacuation du côlon | |
WO2009149058A3 (fr) | Formulations de niacine à libération modifiée | |
WO2010007515A3 (fr) | Système pour l'administration de médicaments par le côlon sous réserve de la dégradation enzymatique et/ou faiblement absorbés dans le tractus gastro-intestinal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10816429 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2010816429 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010816429 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10816429 Country of ref document: EP Kind code of ref document: A2 |